Fig. 1 Flow chart of the enrollment of 28 HCC patients treated with GSMs-TACE. (RFA: radiofrequency ablation; HCC: hepatocellular carcinoma; GSMs-TACE, transarterial chemoembolization with gelatin sponge microparticles)
Table 2 Characteristics of 28 HCC patients who received GSMs-TACE